nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—CYP1A2—Estropipate—osteoporosis	0.106	0.53	CbGbCtD
Zolmitriptan—CYP1A2—Conjugated Estrogens—osteoporosis	0.0502	0.25	CbGbCtD
Zolmitriptan—CYP1A2—Estradiol—osteoporosis	0.0441	0.22	CbGbCtD
Zolmitriptan—Melatonin—CYP19A1—osteoporosis	0.00242	0.521	CrCbGaD
Zolmitriptan—Melatonin—ESR1—osteoporosis	0.00223	0.479	CrCbGaD
Zolmitriptan—Myalgia—Zoledronate—osteoporosis	0.000413	0.000539	CcSEcCtD
Zolmitriptan—Arthralgia—Zoledronate—osteoporosis	0.000413	0.000539	CcSEcCtD
Zolmitriptan—Palpitations—Conjugated Estrogens—osteoporosis	0.000413	0.000539	CcSEcCtD
Zolmitriptan—Insomnia—Risedronate—osteoporosis	0.000413	0.000539	CcSEcCtD
Zolmitriptan—Anxiety—Zoledronate—osteoporosis	0.000412	0.000537	CcSEcCtD
Zolmitriptan—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000411	0.000536	CcSEcCtD
Zolmitriptan—Paraesthesia—Risedronate—osteoporosis	0.00041	0.000535	CcSEcCtD
Zolmitriptan—Pruritus—Estropipate—osteoporosis	0.000408	0.000533	CcSEcCtD
Zolmitriptan—Discomfort—Zoledronate—osteoporosis	0.000408	0.000533	CcSEcCtD
Zolmitriptan—Asthenia—Alendronate—osteoporosis	0.000408	0.000532	CcSEcCtD
Zolmitriptan—Hypersensitivity—Ibandronate—osteoporosis	0.000408	0.000532	CcSEcCtD
Zolmitriptan—Cough—Conjugated Estrogens—osteoporosis	0.000408	0.000532	CcSEcCtD
Zolmitriptan—Dyspnoea—Risedronate—osteoporosis	0.000407	0.000531	CcSEcCtD
Zolmitriptan—Convulsion—Conjugated Estrogens—osteoporosis	0.000405	0.000528	CcSEcCtD
Zolmitriptan—Dry mouth—Zoledronate—osteoporosis	0.000404	0.000527	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000404	0.000527	CcSEcCtD
Zolmitriptan—Pruritus—Alendronate—osteoporosis	0.000402	0.000525	CcSEcCtD
Zolmitriptan—Dyspepsia—Risedronate—osteoporosis	0.000402	0.000524	CcSEcCtD
Zolmitriptan—Tinnitus—Estradiol—osteoporosis	0.000401	0.000523	CcSEcCtD
Zolmitriptan—Constipation—Ethinyl Estradiol—osteoporosis	0.0004	0.000522	CcSEcCtD
Zolmitriptan—Confusional state—Zoledronate—osteoporosis	0.000399	0.000521	CcSEcCtD
Zolmitriptan—Hypersensitivity—Calcitriol—osteoporosis	0.000399	0.000521	CcSEcCtD
Zolmitriptan—Cardiac disorder—Estradiol—osteoporosis	0.000399	0.00052	CcSEcCtD
Zolmitriptan—Chest pain—Conjugated Estrogens—osteoporosis	0.000398	0.000519	CcSEcCtD
Zolmitriptan—Myalgia—Conjugated Estrogens—osteoporosis	0.000398	0.000519	CcSEcCtD
Zolmitriptan—Arthralgia—Conjugated Estrogens—osteoporosis	0.000398	0.000519	CcSEcCtD
Zolmitriptan—Asthenia—Ibandronate—osteoporosis	0.000397	0.000518	CcSEcCtD
Zolmitriptan—Anxiety—Conjugated Estrogens—osteoporosis	0.000396	0.000517	CcSEcCtD
Zolmitriptan—Nausea—Etidronic acid—osteoporosis	0.000396	0.000517	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Zoledronate—osteoporosis	0.000396	0.000517	CcSEcCtD
Zolmitriptan—Oedema—Zoledronate—osteoporosis	0.000396	0.000517	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000395	0.000516	CcSEcCtD
Zolmitriptan—Diarrhoea—Estropipate—osteoporosis	0.000395	0.000515	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Risedronate—osteoporosis	0.000394	0.000514	CcSEcCtD
Zolmitriptan—Infection—Zoledronate—osteoporosis	0.000393	0.000514	CcSEcCtD
Zolmitriptan—Insomnia—Pamidronate—osteoporosis	0.000392	0.000512	CcSEcCtD
Zolmitriptan—Pruritus—Ibandronate—osteoporosis	0.000392	0.000511	CcSEcCtD
Zolmitriptan—Pain—Risedronate—osteoporosis	0.00039	0.000509	CcSEcCtD
Zolmitriptan—Constipation—Risedronate—osteoporosis	0.00039	0.000509	CcSEcCtD
Zolmitriptan—Angiopathy—Estradiol—osteoporosis	0.00039	0.000509	CcSEcCtD
Zolmitriptan—Shock—Zoledronate—osteoporosis	0.00039	0.000509	CcSEcCtD
Zolmitriptan—Paraesthesia—Pamidronate—osteoporosis	0.000389	0.000508	CcSEcCtD
Zolmitriptan—Diarrhoea—Alendronate—osteoporosis	0.000389	0.000508	CcSEcCtD
Zolmitriptan—Asthenia—Calcitriol—osteoporosis	0.000389	0.000507	CcSEcCtD
Zolmitriptan—Nervous system disorder—Zoledronate—osteoporosis	0.000388	0.000507	CcSEcCtD
Zolmitriptan—Immune system disorder—Estradiol—osteoporosis	0.000388	0.000507	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Zoledronate—osteoporosis	0.000388	0.000506	CcSEcCtD
Zolmitriptan—Dyspnoea—Pamidronate—osteoporosis	0.000387	0.000505	CcSEcCtD
Zolmitriptan—Tachycardia—Zoledronate—osteoporosis	0.000387	0.000505	CcSEcCtD
Zolmitriptan—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000386	0.000503	CcSEcCtD
Zolmitriptan—Chills—Estradiol—osteoporosis	0.000385	0.000503	CcSEcCtD
Zolmitriptan—Somnolence—Pamidronate—osteoporosis	0.000385	0.000503	CcSEcCtD
Zolmitriptan—Skin disorder—Zoledronate—osteoporosis	0.000385	0.000502	CcSEcCtD
Zolmitriptan—Pruritus—Calcitriol—osteoporosis	0.000383	0.0005	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Zoledronate—osteoporosis	0.000383	0.0005	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000383	0.000499	CcSEcCtD
Zolmitriptan—Diarrhoea—Raloxifene—osteoporosis	0.000383	0.000499	CcSEcCtD
Zolmitriptan—Dyspepsia—Pamidronate—osteoporosis	0.000382	0.000498	CcSEcCtD
Zolmitriptan—Dizziness—Estropipate—osteoporosis	0.000382	0.000498	CcSEcCtD
Zolmitriptan—Oedema—Conjugated Estrogens—osteoporosis	0.000381	0.000498	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000381	0.000498	CcSEcCtD
Zolmitriptan—Infection—Conjugated Estrogens—osteoporosis	0.000379	0.000495	CcSEcCtD
Zolmitriptan—Diarrhoea—Ibandronate—osteoporosis	0.000379	0.000494	CcSEcCtD
Zolmitriptan—Anorexia—Zoledronate—osteoporosis	0.000378	0.000493	CcSEcCtD
Zolmitriptan—Decreased appetite—Pamidronate—osteoporosis	0.000377	0.000492	CcSEcCtD
Zolmitriptan—Dizziness—Alendronate—osteoporosis	0.000376	0.000491	CcSEcCtD
Zolmitriptan—Shock—Conjugated Estrogens—osteoporosis	0.000375	0.00049	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000374	0.000489	CcSEcCtD
Zolmitriptan—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000374	0.000488	CcSEcCtD
Zolmitriptan—Erythema—Estradiol—osteoporosis	0.000374	0.000488	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Risedronate—osteoporosis	0.000373	0.000487	CcSEcCtD
Zolmitriptan—Tachycardia—Conjugated Estrogens—osteoporosis	0.000372	0.000486	CcSEcCtD
Zolmitriptan—Urticaria—Ethinyl Estradiol—osteoporosis	0.000372	0.000485	CcSEcCtD
Zolmitriptan—Constipation—Pamidronate—osteoporosis	0.000371	0.000484	CcSEcCtD
Zolmitriptan—Pain—Pamidronate—osteoporosis	0.000371	0.000484	CcSEcCtD
Zolmitriptan—Diarrhoea—Calcitriol—osteoporosis	0.000371	0.000484	CcSEcCtD
Zolmitriptan—Skin disorder—Conjugated Estrogens—osteoporosis	0.00037	0.000484	CcSEcCtD
Zolmitriptan—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00037	0.000483	CcSEcCtD
Zolmitriptan—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00037	0.000483	CcSEcCtD
Zolmitriptan—Dizziness—Raloxifene—osteoporosis	0.00037	0.000483	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000369	0.000481	CcSEcCtD
Zolmitriptan—Tension—Estradiol—osteoporosis	0.000367	0.000479	CcSEcCtD
Zolmitriptan—Vomiting—Estropipate—osteoporosis	0.000367	0.000479	CcSEcCtD
Zolmitriptan—Dysgeusia—Estradiol—osteoporosis	0.000366	0.000478	CcSEcCtD
Zolmitriptan—Dizziness—Ibandronate—osteoporosis	0.000366	0.000478	CcSEcCtD
Zolmitriptan—Rash—Estropipate—osteoporosis	0.000364	0.000475	CcSEcCtD
Zolmitriptan—Dermatitis—Estropipate—osteoporosis	0.000364	0.000475	CcSEcCtD
Zolmitriptan—Anorexia—Conjugated Estrogens—osteoporosis	0.000364	0.000475	CcSEcCtD
Zolmitriptan—Nervousness—Estradiol—osteoporosis	0.000363	0.000474	CcSEcCtD
Zolmitriptan—Urticaria—Risedronate—osteoporosis	0.000362	0.000473	CcSEcCtD
Zolmitriptan—Back pain—Estradiol—osteoporosis	0.000362	0.000472	CcSEcCtD
Zolmitriptan—Headache—Estropipate—osteoporosis	0.000362	0.000472	CcSEcCtD
Zolmitriptan—Vomiting—Alendronate—osteoporosis	0.000361	0.000472	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000361	0.000471	CcSEcCtD
Zolmitriptan—Abdominal pain—Risedronate—osteoporosis	0.000361	0.000471	CcSEcCtD
Zolmitriptan—Body temperature increased—Risedronate—osteoporosis	0.000361	0.000471	CcSEcCtD
Zolmitriptan—Muscle spasms—Estradiol—osteoporosis	0.00036	0.000469	CcSEcCtD
Zolmitriptan—Rash—Alendronate—osteoporosis	0.000358	0.000468	CcSEcCtD
Zolmitriptan—Insomnia—Zoledronate—osteoporosis	0.000358	0.000468	CcSEcCtD
Zolmitriptan—Dermatitis—Alendronate—osteoporosis	0.000358	0.000467	CcSEcCtD
Zolmitriptan—Feeling abnormal—Pamidronate—osteoporosis	0.000357	0.000466	CcSEcCtD
Zolmitriptan—Headache—Alendronate—osteoporosis	0.000356	0.000465	CcSEcCtD
Zolmitriptan—Paraesthesia—Zoledronate—osteoporosis	0.000356	0.000464	CcSEcCtD
Zolmitriptan—Vomiting—Raloxifene—osteoporosis	0.000355	0.000464	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Pamidronate—osteoporosis	0.000355	0.000463	CcSEcCtD
Zolmitriptan—Dyspnoea—Zoledronate—osteoporosis	0.000353	0.000461	CcSEcCtD
Zolmitriptan—Rash—Raloxifene—osteoporosis	0.000353	0.00046	CcSEcCtD
Zolmitriptan—Dermatitis—Raloxifene—osteoporosis	0.000352	0.00046	CcSEcCtD
Zolmitriptan—Somnolence—Zoledronate—osteoporosis	0.000352	0.00046	CcSEcCtD
Zolmitriptan—Vomiting—Ibandronate—osteoporosis	0.000352	0.000459	CcSEcCtD
Zolmitriptan—Tremor—Estradiol—osteoporosis	0.00035	0.000457	CcSEcCtD
Zolmitriptan—Headache—Raloxifene—osteoporosis	0.00035	0.000457	CcSEcCtD
Zolmitriptan—Rash—Ibandronate—osteoporosis	0.000349	0.000456	CcSEcCtD
Zolmitriptan—Dermatitis—Ibandronate—osteoporosis	0.000349	0.000455	CcSEcCtD
Zolmitriptan—Dyspepsia—Zoledronate—osteoporosis	0.000349	0.000455	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000347	0.000454	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Estradiol—osteoporosis	0.000347	0.000453	CcSEcCtD
Zolmitriptan—Headache—Ibandronate—osteoporosis	0.000347	0.000453	CcSEcCtD
Zolmitriptan—Insomnia—Conjugated Estrogens—osteoporosis	0.000345	0.00045	CcSEcCtD
Zolmitriptan—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000345	0.00045	CcSEcCtD
Zolmitriptan—Vomiting—Calcitriol—osteoporosis	0.000344	0.00045	CcSEcCtD
Zolmitriptan—Decreased appetite—Zoledronate—osteoporosis	0.000344	0.000449	CcSEcCtD
Zolmitriptan—Agitation—Estradiol—osteoporosis	0.000344	0.000449	CcSEcCtD
Zolmitriptan—Nausea—Estropipate—osteoporosis	0.000343	0.000448	CcSEcCtD
Zolmitriptan—Abdominal pain—Pamidronate—osteoporosis	0.000343	0.000447	CcSEcCtD
Zolmitriptan—Body temperature increased—Pamidronate—osteoporosis	0.000343	0.000447	CcSEcCtD
Zolmitriptan—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000342	0.000447	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000342	0.000446	CcSEcCtD
Zolmitriptan—Angioedema—Estradiol—osteoporosis	0.000342	0.000446	CcSEcCtD
Zolmitriptan—Rash—Calcitriol—osteoporosis	0.000342	0.000446	CcSEcCtD
Zolmitriptan—Dermatitis—Calcitriol—osteoporosis	0.000341	0.000446	CcSEcCtD
Zolmitriptan—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00034	0.000444	CcSEcCtD
Zolmitriptan—Headache—Calcitriol—osteoporosis	0.000339	0.000443	CcSEcCtD
Zolmitriptan—Somnolence—Conjugated Estrogens—osteoporosis	0.000339	0.000443	CcSEcCtD
Zolmitriptan—Constipation—Zoledronate—osteoporosis	0.000339	0.000442	CcSEcCtD
Zolmitriptan—Pain—Zoledronate—osteoporosis	0.000339	0.000442	CcSEcCtD
Zolmitriptan—Nausea—Alendronate—osteoporosis	0.000338	0.000441	CcSEcCtD
Zolmitriptan—Malaise—Estradiol—osteoporosis	0.000337	0.00044	CcSEcCtD
Zolmitriptan—Hypersensitivity—Risedronate—osteoporosis	0.000336	0.000439	CcSEcCtD
Zolmitriptan—Vertigo—Estradiol—osteoporosis	0.000336	0.000439	CcSEcCtD
Zolmitriptan—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000336	0.000438	CcSEcCtD
Zolmitriptan—Asthenia—Ethinyl Estradiol—osteoporosis	0.000336	0.000438	CcSEcCtD
Zolmitriptan—Syncope—Estradiol—osteoporosis	0.000335	0.000438	CcSEcCtD
Zolmitriptan—Nausea—Raloxifene—osteoporosis	0.000332	0.000433	CcSEcCtD
Zolmitriptan—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000332	0.000433	CcSEcCtD
Zolmitriptan—Pruritus—Ethinyl Estradiol—osteoporosis	0.000331	0.000432	CcSEcCtD
Zolmitriptan—Palpitations—Estradiol—osteoporosis	0.000331	0.000431	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000329	0.00043	CcSEcCtD
Zolmitriptan—Nausea—Ibandronate—osteoporosis	0.000329	0.000429	CcSEcCtD
Zolmitriptan—Loss of consciousness—Estradiol—osteoporosis	0.000329	0.000429	CcSEcCtD
Zolmitriptan—Asthenia—Risedronate—osteoporosis	0.000327	0.000427	CcSEcCtD
Zolmitriptan—Feeling abnormal—Zoledronate—osteoporosis	0.000326	0.000426	CcSEcCtD
Zolmitriptan—Cough—Estradiol—osteoporosis	0.000326	0.000426	CcSEcCtD
Zolmitriptan—Pain—Conjugated Estrogens—osteoporosis	0.000326	0.000426	CcSEcCtD
Zolmitriptan—Constipation—Conjugated Estrogens—osteoporosis	0.000326	0.000426	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Zoledronate—osteoporosis	0.000324	0.000423	CcSEcCtD
Zolmitriptan—Hypertension—Estradiol—osteoporosis	0.000323	0.000421	CcSEcCtD
Zolmitriptan—Pruritus—Risedronate—osteoporosis	0.000323	0.000421	CcSEcCtD
Zolmitriptan—Nausea—Calcitriol—osteoporosis	0.000322	0.00042	CcSEcCtD
Zolmitriptan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00032	0.000418	CcSEcCtD
Zolmitriptan—Hypersensitivity—Pamidronate—osteoporosis	0.000319	0.000417	CcSEcCtD
Zolmitriptan—Myalgia—Estradiol—osteoporosis	0.000318	0.000416	CcSEcCtD
Zolmitriptan—Arthralgia—Estradiol—osteoporosis	0.000318	0.000416	CcSEcCtD
Zolmitriptan—Chest pain—Estradiol—osteoporosis	0.000318	0.000416	CcSEcCtD
Zolmitriptan—Anxiety—Estradiol—osteoporosis	0.000317	0.000414	CcSEcCtD
Zolmitriptan—Urticaria—Zoledronate—osteoporosis	0.000315	0.000411	CcSEcCtD
Zolmitriptan—Discomfort—Estradiol—osteoporosis	0.000315	0.000411	CcSEcCtD
Zolmitriptan—Abdominal pain—Zoledronate—osteoporosis	0.000313	0.000409	CcSEcCtD
Zolmitriptan—Body temperature increased—Zoledronate—osteoporosis	0.000313	0.000409	CcSEcCtD
Zolmitriptan—Diarrhoea—Risedronate—osteoporosis	0.000312	0.000407	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000312	0.000407	CcSEcCtD
Zolmitriptan—Dry mouth—Estradiol—osteoporosis	0.000311	0.000406	CcSEcCtD
Zolmitriptan—Asthenia—Pamidronate—osteoporosis	0.000311	0.000406	CcSEcCtD
Zolmitriptan—Dizziness—Ethinyl Estradiol—osteoporosis	0.000309	0.000404	CcSEcCtD
Zolmitriptan—Confusional state—Estradiol—osteoporosis	0.000308	0.000402	CcSEcCtD
Zolmitriptan—Pruritus—Pamidronate—osteoporosis	0.000307	0.0004	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Estradiol—osteoporosis	0.000305	0.000398	CcSEcCtD
Zolmitriptan—Oedema—Estradiol—osteoporosis	0.000305	0.000398	CcSEcCtD
Zolmitriptan—Infection—Estradiol—osteoporosis	0.000303	0.000396	CcSEcCtD
Zolmitriptan—Urticaria—Conjugated Estrogens—osteoporosis	0.000303	0.000395	CcSEcCtD
Zolmitriptan—Dizziness—Risedronate—osteoporosis	0.000302	0.000394	CcSEcCtD
Zolmitriptan—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000301	0.000394	CcSEcCtD
Zolmitriptan—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000301	0.000394	CcSEcCtD
Zolmitriptan—Shock—Estradiol—osteoporosis	0.0003	0.000392	CcSEcCtD
Zolmitriptan—Nervous system disorder—Estradiol—osteoporosis	0.000299	0.000391	CcSEcCtD
Zolmitriptan—Tachycardia—Estradiol—osteoporosis	0.000298	0.000389	CcSEcCtD
Zolmitriptan—Vomiting—Ethinyl Estradiol—osteoporosis	0.000297	0.000388	CcSEcCtD
Zolmitriptan—Diarrhoea—Pamidronate—osteoporosis	0.000297	0.000387	CcSEcCtD
Zolmitriptan—Skin disorder—Estradiol—osteoporosis	0.000296	0.000387	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Estradiol—osteoporosis	0.000295	0.000385	CcSEcCtD
Zolmitriptan—Rash—Ethinyl Estradiol—osteoporosis	0.000295	0.000385	CcSEcCtD
Zolmitriptan—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000295	0.000385	CcSEcCtD
Zolmitriptan—Headache—Ethinyl Estradiol—osteoporosis	0.000293	0.000383	CcSEcCtD
Zolmitriptan—Hypersensitivity—Zoledronate—osteoporosis	0.000292	0.000381	CcSEcCtD
Zolmitriptan—Vomiting—Risedronate—osteoporosis	0.00029	0.000379	CcSEcCtD
Zolmitriptan—Rash—Risedronate—osteoporosis	0.000288	0.000375	CcSEcCtD
Zolmitriptan—Dermatitis—Risedronate—osteoporosis	0.000287	0.000375	CcSEcCtD
Zolmitriptan—Dizziness—Pamidronate—osteoporosis	0.000287	0.000374	CcSEcCtD
Zolmitriptan—Headache—Risedronate—osteoporosis	0.000286	0.000373	CcSEcCtD
Zolmitriptan—Asthenia—Zoledronate—osteoporosis	0.000284	0.000371	CcSEcCtD
Zolmitriptan—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000281	0.000367	CcSEcCtD
Zolmitriptan—Pruritus—Zoledronate—osteoporosis	0.00028	0.000366	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000278	0.000363	CcSEcCtD
Zolmitriptan—Nausea—Ethinyl Estradiol—osteoporosis	0.000278	0.000363	CcSEcCtD
Zolmitriptan—Insomnia—Estradiol—osteoporosis	0.000276	0.00036	CcSEcCtD
Zolmitriptan—Vomiting—Pamidronate—osteoporosis	0.000276	0.00036	CcSEcCtD
Zolmitriptan—Paraesthesia—Estradiol—osteoporosis	0.000274	0.000358	CcSEcCtD
Zolmitriptan—Asthenia—Conjugated Estrogens—osteoporosis	0.000274	0.000357	CcSEcCtD
Zolmitriptan—Rash—Pamidronate—osteoporosis	0.000273	0.000357	CcSEcCtD
Zolmitriptan—Dermatitis—Pamidronate—osteoporosis	0.000273	0.000357	CcSEcCtD
Zolmitriptan—Dyspnoea—Estradiol—osteoporosis	0.000272	0.000355	CcSEcCtD
Zolmitriptan—Headache—Pamidronate—osteoporosis	0.000272	0.000355	CcSEcCtD
Zolmitriptan—Somnolence—Estradiol—osteoporosis	0.000271	0.000354	CcSEcCtD
Zolmitriptan—Diarrhoea—Zoledronate—osteoporosis	0.000271	0.000354	CcSEcCtD
Zolmitriptan—Nausea—Risedronate—osteoporosis	0.000271	0.000354	CcSEcCtD
Zolmitriptan—Pruritus—Conjugated Estrogens—osteoporosis	0.00027	0.000352	CcSEcCtD
Zolmitriptan—Dyspepsia—Estradiol—osteoporosis	0.000269	0.000351	CcSEcCtD
Zolmitriptan—Decreased appetite—Estradiol—osteoporosis	0.000265	0.000346	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Estradiol—osteoporosis	0.000264	0.000344	CcSEcCtD
Zolmitriptan—Dizziness—Zoledronate—osteoporosis	0.000262	0.000342	CcSEcCtD
Zolmitriptan—Constipation—Estradiol—osteoporosis	0.000261	0.000341	CcSEcCtD
Zolmitriptan—Pain—Estradiol—osteoporosis	0.000261	0.000341	CcSEcCtD
Zolmitriptan—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000261	0.000341	CcSEcCtD
Zolmitriptan—Nausea—Pamidronate—osteoporosis	0.000258	0.000336	CcSEcCtD
Zolmitriptan—Dizziness—Conjugated Estrogens—osteoporosis	0.000252	0.000329	CcSEcCtD
Zolmitriptan—Vomiting—Zoledronate—osteoporosis	0.000252	0.000329	CcSEcCtD
Zolmitriptan—Feeling abnormal—Estradiol—osteoporosis	0.000252	0.000328	CcSEcCtD
Zolmitriptan—Rash—Zoledronate—osteoporosis	0.00025	0.000326	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Estradiol—osteoporosis	0.00025	0.000326	CcSEcCtD
Zolmitriptan—Dermatitis—Zoledronate—osteoporosis	0.00025	0.000326	CcSEcCtD
Zolmitriptan—Headache—Zoledronate—osteoporosis	0.000248	0.000324	CcSEcCtD
Zolmitriptan—Vomiting—Conjugated Estrogens—osteoporosis	0.000242	0.000317	CcSEcCtD
Zolmitriptan—Urticaria—Estradiol—osteoporosis	0.000242	0.000317	CcSEcCtD
Zolmitriptan—Abdominal pain—Estradiol—osteoporosis	0.000241	0.000315	CcSEcCtD
Zolmitriptan—Body temperature increased—Estradiol—osteoporosis	0.000241	0.000315	CcSEcCtD
Zolmitriptan—Rash—Conjugated Estrogens—osteoporosis	0.00024	0.000314	CcSEcCtD
Zolmitriptan—Dermatitis—Conjugated Estrogens—osteoporosis	0.00024	0.000314	CcSEcCtD
Zolmitriptan—Headache—Conjugated Estrogens—osteoporosis	0.000239	0.000312	CcSEcCtD
Zolmitriptan—Nausea—Zoledronate—osteoporosis	0.000235	0.000307	CcSEcCtD
Zolmitriptan—Nausea—Conjugated Estrogens—osteoporosis	0.000227	0.000296	CcSEcCtD
Zolmitriptan—Hypersensitivity—Estradiol—osteoporosis	0.000225	0.000294	CcSEcCtD
Zolmitriptan—Asthenia—Estradiol—osteoporosis	0.000219	0.000286	CcSEcCtD
Zolmitriptan—Pruritus—Estradiol—osteoporosis	0.000216	0.000282	CcSEcCtD
Zolmitriptan—Diarrhoea—Estradiol—osteoporosis	0.000209	0.000273	CcSEcCtD
Zolmitriptan—Dizziness—Estradiol—osteoporosis	0.000202	0.000263	CcSEcCtD
Zolmitriptan—Vomiting—Estradiol—osteoporosis	0.000194	0.000253	CcSEcCtD
Zolmitriptan—Rash—Estradiol—osteoporosis	0.000192	0.000251	CcSEcCtD
Zolmitriptan—Dermatitis—Estradiol—osteoporosis	0.000192	0.000251	CcSEcCtD
Zolmitriptan—Headache—Estradiol—osteoporosis	0.000191	0.00025	CcSEcCtD
Zolmitriptan—Nausea—Estradiol—osteoporosis	0.000181	0.000237	CcSEcCtD
Zolmitriptan—HTR1F—Signaling Pathways—TLN1—osteoporosis	7.3e-05	0.00253	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PTH—osteoporosis	7.3e-05	0.00253	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTH1R—osteoporosis	7.3e-05	0.00253	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CALCR—osteoporosis	7.3e-05	0.00253	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	7.21e-05	0.0025	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.17e-05	0.00248	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PTH—osteoporosis	7.15e-05	0.00248	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CNR2—osteoporosis	7.12e-05	0.00246	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CALCA—osteoporosis	7.03e-05	0.00243	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CNR2—osteoporosis	6.97e-05	0.00241	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.79e-05	0.00235	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PTH—osteoporosis	6.63e-05	0.0023	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PTH—osteoporosis	6.49e-05	0.00225	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	6.48e-05	0.00224	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CNR2—osteoporosis	6.46e-05	0.00224	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—OXCT1—osteoporosis	6.38e-05	0.00221	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CA2—osteoporosis	6.38e-05	0.00221	CbGpPWpGaD
Zolmitriptan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.37e-05	0.00221	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	6.34e-05	0.0022	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CNR2—osteoporosis	6.33e-05	0.00219	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—P4HB—osteoporosis	6.3e-05	0.00218	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—osteoporosis	6.26e-05	0.00217	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—MGLL—osteoporosis	6.22e-05	0.00215	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SOST—osteoporosis	6.15e-05	0.00213	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PTH—osteoporosis	6.13e-05	0.00212	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—POMC—osteoporosis	6.08e-05	0.0021	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—WNT1—osteoporosis	6.08e-05	0.0021	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PTHLH—osteoporosis	6.05e-05	0.0021	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RAP1A—osteoporosis	6.02e-05	0.00208	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CNR2—osteoporosis	5.97e-05	0.00207	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—WNT1—osteoporosis	5.95e-05	0.00206	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—ADCY5—osteoporosis	5.92e-05	0.00205	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PTHLH—osteoporosis	5.92e-05	0.00205	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MGLL—osteoporosis	5.92e-05	0.00205	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NFATC1—osteoporosis	5.87e-05	0.00203	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—DKK1—osteoporosis	5.83e-05	0.00202	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MGLL—osteoporosis	5.8e-05	0.00201	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LRP5—osteoporosis	5.78e-05	0.002	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LRP5—osteoporosis	5.66e-05	0.00196	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	5.63e-05	0.00195	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	5.62e-05	0.00195	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—WNT1—osteoporosis	5.61e-05	0.00194	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	5.6e-05	0.00194	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CALCR—osteoporosis	5.56e-05	0.00193	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTH1R—osteoporosis	5.56e-05	0.00193	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	5.55e-05	0.00192	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LRP6—osteoporosis	5.53e-05	0.00191	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PTHLH—osteoporosis	5.49e-05	0.0019	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—FGA—osteoporosis	5.46e-05	0.00189	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PTH—osteoporosis	5.45e-05	0.00189	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LRP6—osteoporosis	5.41e-05	0.00187	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—ADCY5—osteoporosis	5.38e-05	0.00186	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PTHLH—osteoporosis	5.38e-05	0.00186	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—TNF—osteoporosis	5.34e-05	0.00185	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CALCA—osteoporosis	5.33e-05	0.00184	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CNR2—osteoporosis	5.31e-05	0.00184	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—IDH2—osteoporosis	5.29e-05	0.00183	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.28e-05	0.00183	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	5.23e-05	0.00181	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	5.23e-05	0.00181	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CALCA—osteoporosis	5.22e-05	0.00181	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.15e-05	0.00178	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PTHLH—osteoporosis	5.08e-05	0.00176	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—BMP2—osteoporosis	5.08e-05	0.00176	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP27A1—osteoporosis	4.97e-05	0.00172	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—FGB—osteoporosis	4.97e-05	0.00172	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PTH—osteoporosis	4.95e-05	0.00171	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—POMC—osteoporosis	4.93e-05	0.00171	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CALCA—osteoporosis	4.84e-05	0.00167	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ACP5—osteoporosis	4.83e-05	0.00167	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	4.83e-05	0.00167	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—POMC—osteoporosis	4.83e-05	0.00167	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CNR2—osteoporosis	4.82e-05	0.00167	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PSMA2—osteoporosis	4.79e-05	0.00166	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PSMA5—osteoporosis	4.79e-05	0.00166	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CALCA—osteoporosis	4.74e-05	0.00164	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TLN1—osteoporosis	4.67e-05	0.00162	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TLN1—osteoporosis	4.57e-05	0.00158	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—TNF—osteoporosis	4.54e-05	0.00157	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—WNT1—osteoporosis	4.53e-05	0.00157	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PTHLH—osteoporosis	4.51e-05	0.00156	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—TPI1—osteoporosis	4.49e-05	0.00156	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CALCA—osteoporosis	4.47e-05	0.00155	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MGLL—osteoporosis	4.42e-05	0.00153	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—POMC—osteoporosis	4.36e-05	0.00151	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LRP5—osteoporosis	4.31e-05	0.00149	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL6—osteoporosis	4.31e-05	0.00149	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—P4HB—osteoporosis	4.23e-05	0.00146	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GAPDH—osteoporosis	4.15e-05	0.00144	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LRP6—osteoporosis	4.12e-05	0.00143	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.12e-05	0.00143	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PTHLH—osteoporosis	4.1e-05	0.00142	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KL—osteoporosis	4.06e-05	0.0014	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—RAP1A—osteoporosis	4.04e-05	0.0014	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—P4HB—osteoporosis	4.03e-05	0.00139	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CALCA—osteoporosis	3.97e-05	0.00138	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—POMC—osteoporosis	3.96e-05	0.00137	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—P4HB—osteoporosis	3.94e-05	0.00137	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTH—osteoporosis	3.92e-05	0.00136	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6R—osteoporosis	3.86e-05	0.00134	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RAP1A—osteoporosis	3.85e-05	0.00133	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTH—osteoporosis	3.84e-05	0.00133	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CNR2—osteoporosis	3.82e-05	0.00132	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—ADCY5—osteoporosis	3.79e-05	0.00131	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RAP1A—osteoporosis	3.77e-05	0.00131	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NFATC1—osteoporosis	3.76e-05	0.0013	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CNR2—osteoporosis	3.74e-05	0.00129	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—DKK1—osteoporosis	3.73e-05	0.00129	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—ADCY5—osteoporosis	3.71e-05	0.00128	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—POMC—osteoporosis	3.68e-05	0.00127	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NFATC1—osteoporosis	3.68e-05	0.00127	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL6—osteoporosis	3.66e-05	0.00127	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—DKK1—osteoporosis	3.65e-05	0.00126	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CALCA—osteoporosis	3.61e-05	0.00125	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—WNT1—osteoporosis	3.59e-05	0.00124	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—WNT1—osteoporosis	3.51e-05	0.00122	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.5e-05	0.00121	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FGA—osteoporosis	3.49e-05	0.00121	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TLN1—osteoporosis	3.48e-05	0.00121	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—ADCY5—osteoporosis	3.44e-05	0.00119	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FGA—osteoporosis	3.42e-05	0.00118	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—POMC—osteoporosis	3.38e-05	0.00117	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—ADCY5—osteoporosis	3.37e-05	0.00117	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ENO1—osteoporosis	3.27e-05	0.00113	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTHLH—osteoporosis	3.25e-05	0.00112	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BMP2—osteoporosis	3.25e-05	0.00112	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PSMA2—osteoporosis	3.22e-05	0.00111	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PSMA5—osteoporosis	3.22e-05	0.00111	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PKM—osteoporosis	3.19e-05	0.0011	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—FDPS—osteoporosis	3.19e-05	0.0011	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ADCY5—osteoporosis	3.18e-05	0.0011	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTHLH—osteoporosis	3.18e-05	0.0011	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BMP2—osteoporosis	3.18e-05	0.0011	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FGB—osteoporosis	3.18e-05	0.0011	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FGB—osteoporosis	3.11e-05	0.00108	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SPP1—osteoporosis	3.07e-05	0.00106	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PSMA2—osteoporosis	3.07e-05	0.00106	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PSMA5—osteoporosis	3.07e-05	0.00106	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PGLS—osteoporosis	3.03e-05	0.00105	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GPD2—osteoporosis	3.03e-05	0.00105	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—P4HB—osteoporosis	3e-05	0.00104	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PSMA2—osteoporosis	3e-05	0.00104	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PSMA5—osteoporosis	3e-05	0.00104	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTH—osteoporosis	2.92e-05	0.00101	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RAP1A—osteoporosis	2.87e-05	0.000994	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CALCA—osteoporosis	2.86e-05	0.000989	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CNR2—osteoporosis	2.85e-05	0.000986	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—ADCY5—osteoporosis	2.83e-05	0.000979	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NFATC1—osteoporosis	2.8e-05	0.00097	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CALCA—osteoporosis	2.8e-05	0.000969	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—POMC—osteoporosis	2.79e-05	0.000965	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IRS2—osteoporosis	2.78e-05	0.000963	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—DKK1—osteoporosis	2.78e-05	0.000962	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ATIC—osteoporosis	2.77e-05	0.000958	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PNP—osteoporosis	2.77e-05	0.000958	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—POMC—osteoporosis	2.73e-05	0.000945	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—LEP—osteoporosis	2.72e-05	0.000942	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—WNT1—osteoporosis	2.68e-05	0.000927	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP19A1—osteoporosis	2.61e-05	0.000904	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGA—osteoporosis	2.6e-05	0.000902	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ESR1—osteoporosis	2.6e-05	0.0009	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KL—osteoporosis	2.59e-05	0.000898	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—ADCY5—osteoporosis	2.57e-05	0.000889	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KL—osteoporosis	2.54e-05	0.00088	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—POMC—osteoporosis	2.53e-05	0.000876	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—POMC—osteoporosis	2.48e-05	0.000858	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6R—osteoporosis	2.47e-05	0.000855	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IRS1—osteoporosis	2.43e-05	0.000841	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BMP2—osteoporosis	2.42e-05	0.000838	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTHLH—osteoporosis	2.42e-05	0.000838	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6R—osteoporosis	2.42e-05	0.000837	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGB—osteoporosis	2.37e-05	0.00082	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—OXCT1—osteoporosis	2.35e-05	0.000815	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CA2—osteoporosis	2.35e-05	0.000815	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—POMC—osteoporosis	2.34e-05	0.00081	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MGLL—osteoporosis	2.29e-05	0.000794	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PSMA5—osteoporosis	2.29e-05	0.000792	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PSMA2—osteoporosis	2.29e-05	0.000792	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6R—osteoporosis	2.28e-05	0.00079	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IGF1—osteoporosis	2.25e-05	0.000779	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.16e-05	0.000749	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ADCY5—osteoporosis	2.13e-05	0.000739	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CALCA—osteoporosis	2.13e-05	0.000738	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GPX1—osteoporosis	2.13e-05	0.000736	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—POMC—osteoporosis	2.08e-05	0.00072	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ADCY5—osteoporosis	2.03e-05	0.000704	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ADCY5—osteoporosis	1.99e-05	0.000689	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SPP1—osteoporosis	1.97e-05	0.000681	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—MTHFR—osteoporosis	1.96e-05	0.000679	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—IDH2—osteoporosis	1.95e-05	0.000675	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KL—osteoporosis	1.94e-05	0.00067	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SPP1—osteoporosis	1.93e-05	0.000667	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—POMC—osteoporosis	1.89e-05	0.000654	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6R—osteoporosis	1.84e-05	0.000638	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.83e-05	0.000635	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ACP5—osteoporosis	1.78e-05	0.000617	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IRS2—osteoporosis	1.78e-05	0.000616	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.76e-05	0.00061	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IRS2—osteoporosis	1.74e-05	0.000603	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LEP—osteoporosis	1.74e-05	0.000603	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—osteoporosis	1.72e-05	0.000595	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LEP—osteoporosis	1.7e-05	0.00059	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.66e-05	0.000575	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TPI1—osteoporosis	1.66e-05	0.000574	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.63e-05	0.000563	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—POMC—osteoporosis	1.57e-05	0.000543	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—P4HB—osteoporosis	1.56e-05	0.00054	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.55e-05	0.000538	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GAPDH—osteoporosis	1.53e-05	0.00053	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.52e-05	0.000526	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.52e-05	0.000525	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—POMC—osteoporosis	1.5e-05	0.000518	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—RAP1A—osteoporosis	1.49e-05	0.000516	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.47e-05	0.000508	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—POMC—osteoporosis	1.46e-05	0.000507	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.46e-05	0.000505	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.44e-05	0.000498	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.43e-05	0.000494	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.41e-05	0.000488	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MYC—osteoporosis	1.35e-05	0.000468	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TGFB1—osteoporosis	1.35e-05	0.000467	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.33e-05	0.000459	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.3e-05	0.00045	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LEP—osteoporosis	1.3e-05	0.000449	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.24e-05	0.000429	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ENO1—osteoporosis	1.2e-05	0.000417	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PSMA2—osteoporosis	1.19e-05	0.000411	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PSMA5—osteoporosis	1.19e-05	0.000411	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.16e-05	0.000401	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—POMC—osteoporosis	1.12e-05	0.000386	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.1e-05	0.000381	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.09e-05	0.000377	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.08e-05	0.000373	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.07e-05	0.000371	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—osteoporosis	1.02e-05	0.000352	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP19A1—osteoporosis	9.63e-06	0.000333	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MYC—osteoporosis	8.64e-06	0.000299	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TGFB1—osteoporosis	8.62e-06	0.000299	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MYC—osteoporosis	8.46e-06	0.000293	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TGFB1—osteoporosis	8.44e-06	0.000292	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—osteoporosis	8.2e-06	0.000284	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ADCY5—osteoporosis	7.87e-06	0.000272	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GPX1—osteoporosis	7.84e-06	0.000271	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTHFR—osteoporosis	7.23e-06	0.000251	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—osteoporosis	6.5e-06	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MYC—osteoporosis	6.45e-06	0.000223	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFB1—osteoporosis	6.43e-06	0.000223	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—osteoporosis	6.36e-06	0.00022	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—POMC—osteoporosis	5.79e-06	0.0002	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—osteoporosis	4.85e-06	0.000168	CbGpPWpGaD
